New horizons for autoimmune hyperthyroidism with FcRn blockers. (PubMed, Curr Opin Endocrinol Diabetes Obes) - Aug 7, 2026 - "FcRn blockade is a promising new therapeutic approach for the management of autoimmune hyperthyroidism. Durability, cost-effectiveness and patient selection remain to be defined."
Journal • Endocrine Disorders • Grave's Disease • Immunology • Ophthalmology • Thyroid Eye Disease
|
|
Fearghas Middleton; Prakash Abraham
|